Table 2a.
Changes in Striatal VMAT2 Availability after 4–6 months of STN DBS in Parkinson's Disease (Distribution Volume Ratios [DVR's] Mean ± Standard deviations).
| Region | Pre- Operative |
On STN DBS | % Change |
|---|---|---|---|
| Dorsal Caudate | 1.07 ± 0.44 | 0.86 ± .35* | −17 ± 15 |
| Posterior Caudate | 0.77 ± 0.37 | 0.40 ± 0.25** | −49 ± 22 |
| Anterior Putamen | 0.77 ± 0.13 | 0.71 ± 0.13 | −7 ± 9 |
| Posterior Putamen | 0.54 ± 0.11 | 0.46 ± 0.08** | −15 ± 7 |
| Associative Striatum | 0.90 ± 0.33 | 0.69 ± 0.24* | −22 ± 11 |
| Ventral Striatum | 1.20 ± 0.31 | 1.08 ± 0.21 | −9 ± 8 |
Significant within group difference (p < 0.05).
Significant within group difference (p < 0.01).